Table 1.
The enriched GO terms and KEGG pathways for the down-regulated DEGs.
Category | Term | Description | Count | Genes | P value | FDR |
BP | GO:0030198 | Extracellular matrix organization | 10 | B4GALT1, COL7A1, FBN1, POSTN, COL1A1, LOX, COL8A1, LOXL1, ITGAM, COL5A1 | 1.38E-06 | 2.00E-03 |
BP | GO:0030574 | Collagen catabolic process | 7 | COL7A1, MMP19, COL1A1, MMP14, COL8A1, MMP2, COL5A1 | 1.42E-06 | 2.00E-03 |
BP | GO:0002504 | Antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 5 | HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-DRA | 1.99E-06 | 3.00E-03 |
CC | GO:0031012 | Extracellular matrix | 13 | ACTG1, HMCN1, COL7A1, MMP19, FBN1, POSTN, COL1A1, LOXL2, COL8A1, MMP14, MMP2, LOXL1, COL5A1 | 5.63E-08 | 6.95E-05 |
CC | GO:0030666 | Endocytic vesicle membrane | 7 | WNT5B, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-DRA, CD163 | 1.37E-06 | 2.00E-03 |
CC | GO:0042613 | MHC class II protein complex | 5 | HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-DRA | 5.13E-06 | 6.00E-03 |
MF | GO:0042605 | Peptide antigen binding | 6 | HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, SLC7A5, HLA-DRA | 4.27E-07 | 5.33E-04 |
KEGG | hsa05150 | Staphylococcus aureus infection | 8 | C3AR1, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, FCGR3A, ITGAM, HLA-DRA | 1.87E-07 | 2.20E-04 |
KEGG | hsa05140 | Leishmaniasis | 8 | IRAK1, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, FCGR3A, ITGAM, HLA-DRA | 1.26E-06 | 1.49E-03 |
KEGG | hsa04145 | Phagosome | 9 | ACTG1, ATP6V1A, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, FCGR3A, ITGAM, HLA-DRA | 2.17E-05 | 2.55E-02 |
BPs = biological processes, DEGs = differentially-expressed genes, GO = gene ontology, MF = molecular function, MHC = major histocompatibility complex.